IDH2 and glioma: Diffuse gliomas in adults are therefore now well characterized from a molecular point of view; however, there is still no molecular tool for monitoring these patients longitudinally, even though a low-grade mutated IDH tumor will invariably evolve into a higher-grade tumor [6].